Possibilities of personalized therapy in patients with chronic pelvic pain and inflammatory diseases of the pelvic organs.

In: Medicni perspektivi (Medical perspectives) · 2018 · vol. 23(4) , pp. 68–74 · doi:10.26641/2307-0404.2018.4.153001 · W2908256989
article OA: diamond CC0
AI-generated summary by claude@2026-06, 2026-06-07

This study investigated individualized therapy for chronic pelvic pain by analyzing immune-hormonal profiles and psychological factors, finding significant improvements in pain, hormonal balance, and psycho-emotional states after treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

The paper aimed to develop a pathogenetically determined systemic approach for personalized therapeutic and rehabilitation tactics for women with chronic pelvic pain and inflammatory diseases of pelvic organs, using immune-hormonal relationships and psychopersonal characteristics. It compared changes in cytokines (IL-10, IL-6, TNF-α) and hormonal profiles (LH, FSH, estradiol, progesterone, prolactin, cortisol) and tracked pain and psycho-emotional status over 6 months after treatment. The authors report reduced pro-inflammatory cytokine activity (IL-6 and TNF-α), normalization of hormonal ratios in most women, improvement in general and psychoemotional state, normalization of reactive anxiety/depressive disorders in many patients, and marked regression of pain by VAS in nearly all participants. The paper’s main limitation is that it provides results without detailing study design details such as control/comparator groups in the text provided. This paper is centrally about endometriosis and/or adenomyosis; it focuses on personalized therapy for chronic pelvic pain associated with inflammatory pelvic organ diseases, a category that overlaps clinically with endometriosis and adenomyosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The aim of our study was to create a pathogenetically determined systemic approach to improve the treatment and the psycho-emotional state of a woman with chronic pelvic pain and inflammatory diseases of the pelvic organs through the individualization of therapeutic and rehabilitation tactics on the basis of the study of immune-hormonal relations, and psychopersonal characteristics of thematic patients.A comparative evaluation of the cytokine (IL-10, IL-6, TNF-α) and hormonal profile (luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, progesterone, prolactin,cortisol) was carried out as well as; monitoring of pain and psycho-emotional disorders of the dynamics of observation.In the dynamics of observation after the treatment for 6 months it was noted: a decrease in the pro-inflammatory activity of the cytokine profile: IL-6 by 43.28%, TNF-α by 63.27%;recovery of hormonal ratios – in76% of women;88% of patients identified a significant improvement in general and psychoemotional state;reduction of reactive anxiety and depressive disorders to normal values was determined in 84% of patients; regression of pain syndrome to the minimum indices according to the VAS scale was determined in 96% of patients. This demonstrates the effectiveness of personalized therapy and the possibility of expanding the therapeutic - diagnostic algorithm in patients with chronic pelvic pain.
Full text 5,634 characters · extracted from oa-doi-fallback · click to expand
Possibilities of personalized therapy in patients with chronic pelvic pain and inflammatory diseases of the pelvic organs. DOI: https://doi.org/10.26641/2307-0404.2018.4.153001Keywords: chronic pelvic pain, inflammatory diseases of the pelvic organs, interleukins, personalized therapyAbstract The aim of our study was to create a pathogenetically determined systemic approach to improve the treatment and the psycho-emotional state of a woman with chronic pelvic pain and inflammatory diseases of the pelvic organs through the individualization of therapeutic and rehabilitation tactics on the basis of the study of immune-hormonal relations, and psychopersonal characteristics of thematic patients.A comparative evaluation of the cytokine (IL-10, IL-6, TNF-α) and hormonal profile (luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, progesterone, prolactin,cortisol) was carried out as well as; monitoring of pain and psycho-emotional disorders of the dynamics of observation.In the dynamics of observation after the treatment for 6 months it was noted: a decrease in the pro-inflammatory activity of the cytokine profile: IL-6 by 43.28%, TNF-α by 63.27%;recovery of hormonal ratios – in76% of women;88% of patients identified a significant improvement in general and psychoemotional state;reduction of reactive anxiety and depressive disorders to normal values was determined in 84% of patients; regression of pain syndrome to the minimum indices according to the VAS scale was determined in 96% of patients. This demonstrates the effectiveness of personalized therapy and the possibility of expanding the therapeutic - diagnostic algorithm in patients with chronic pelvic pain. References Moskalenko VF, GulchIy OP, Golubchikov MV. [Biostatistika]. Kyiv, Knigaplyus. 2009;184. Ukrainian. Tatarchuk TF, Kosey NV, Regeda SI, Yarotskaya NV. [Hyperprolactinemia in the genesis of stress-induced infertility. Phytotherapy opportunities]. Zdorove zhenshchiny. 2017;3:28-37. Russian. Danilov AB, Danilov AB. [Biopsychosocial concept of pain]. Manage pain. 2013;1:7-11. Russian. Zhuk SI, Nochvina OA, Kaminskyi AV. [Chronic pelvic pain syndrome in the genesis of stress-induced infertility in women of reproductive age]. Reproduktyvna endokrinologiia. 2015;6(26):12-17. Ukrainian. Kryizhanovskiy GN. [Neuroimmune-endocrine interactions in health and disease]. Moskva, Medkniga. 2010;287. Russian. Neimark AI, Shelkovnikova NV. [The role of inflammatory diseases of the genitals and lower urinary tract in the development of chronic pelvic pain syndrome in women]. Problemy klinicheskoi meditsiny. 2011;25(3/4):56-58. Russian. Rebrova OYu. [Statistical analysis of medical data. Application package STATISTICA]. Moskva, Media-Sfera. 2006;312. Russian. Dubossarskaya ZM, Dubossarskaya YuA, Grek LP, Ushakova TB. [Modern view on the problem of inflammatory diseases of the pelvic organs in women]. Zdorove zhenschiny. 2017;6(122):58-62. Russian. Stenyaeva NN, Apolihina IA. [Chronic pelvic pain: psychosomatic aspects]. Consilium Medicum. 2012;6:19-12. Russian. [Therapy of chronic pelvic pain in women who first applied for medical assistance. Management of the Royal College of Obstetrics and Gynecology of Great Britain]. Zhinochyi likar. 2016;6:49-56. Ukrainian. Harchenko YuA. [An adequate assessment of pain is a pledge of its successful treatment]. Universum, Meditsina i farmakologiya. 2014;4(5). Available from: http://7universum.com/ru/med/archive/item/1229. Ukrainian. Belovа AN, Krupina VN. edit. [Chronic pelvic pain: a guide for doctors]. Moskva, Antidor. 2007;572. Russian. Ma Н, Hong М, Duan J. Altered cytokine gene expression in peripheral blood monocytes across the menstrual cycle in primary dysmenorrhea: a case-control study. PLoS One. 2013;8(2):e55200. Cheong Y, William Stones Y. Chronic pelvic pain: aetiology and therapy. Best Pract. Res. Clin. Obstet. Gynaecol. 2006;20(5):695-711. Poleshuck ЕL, Talbot NL, Moynihan JA, Chapman BP. Depressive symptoms, pain, chronic medical morbidity, and interleukin-6 among primary care patients. Pain Med. 2013;14:686-91. Gunter J. Neurobiology of chronic pelvic pain. Chronic Pelvic Pain. P. Vercellini. London, UK: Blackwell Publishing. 2011;1-6. Dowlati Y, Herrmann N, Swardfager W, Liu H. Meta-Analysis of Cytokines in Major Depression. Biol. Psychiatry. 2010;67:446-57. Sommer C, Kress М. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanism in inflammatory and neuropathic hyperalgesia. Neurosci. Lett. 2004;361:184-7. Wiech K, Tracey I. Influence of negative emotions on pain: behavioral effects and neural mechanisms. Neuroimage. 2009;47:987-97. Downloads How to Cite Issue Section License Copyright (c) 2018 Medicni perspektivi (Medical perspectives) This work is licensed under a Creative Commons Attribution 4.0 International License. Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site. Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Outcome instruments

VAS-pain

Condition tags

chronic_pelvic_pain

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (9)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK